BioNexus Gene Lab (BGLC) Capital Leases (2018 - 2026)
BioNexus Gene Lab (BGLC) posted Capital Leases of $46605.0 for Q1 2026, up 257.92% sequentially from $13021.0 in Q1 2022.
BioNexus Gene Lab (BGLC) Capital Leases (2018 - 2026) Analysis & Trends
BioNexus Gene Lab has reported Capital Leases for 6 years, with the latest figure at $46605.0 in Q1 2026.
- Quarterly Capital Leases changed N/A year-over-year to $46605.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46605.0 (changed N/A YoY) and the FY2021 annual result came in at $12803.0, down 63.72% from the prior year.
- Capital Leases grew to $46605.0 in Q1 2026 per BGLC's latest filing, from $13021.0 in the prior quarter.
- Over five years, Capital Leases peaked at $46605.0 in Q1 2026 and troughed at $13021.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 225.21 Bn | 220.31 Bn | 4.43 Bn |
| 2 | Sherwin Williams | 84.64 Bn | 84.34 Bn | 3.34 Bn |
| 3 | Ecolab | 78.48 Bn | 73.34 Bn | 1.95 Bn |
| 4 | Air Products & Chemicals | 68.23 Bn | 67.25 Bn | 1.04 Bn |
| 5 | Ppg Industries | 25.34 Bn | 23.75 Bn | 1.81 Bn |
| 6 | Chemical & Mining Co Of Chile | 23.53 Bn | 19.66 Bn | 778.60 Mn |
| 7 | LyondellBasell Industries | 21.98 Bn | 19.35 Bn | 2.04 Bn |
| 8 | International Flavors & Fragrances | 21.44 Bn | 20.87 Bn | 853.00 Mn |
| 9 | DuPont de Nemours | 18.88 Bn | 17.14 Bn | 639.00 Mn |
| 10 | BioNexus Gene Lab | 2.28 Mn | -1.25 Mn | 12,982.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,605.00 |
| Mar 31, 2022 | 13,021.00 |
| Dec 31, 2021 | 12,803.00 |
| Sep 30, 2021 | 18,103.00 |
| Jun 30, 2021 | 23,610.00 |
| Mar 31, 2021 | 28,948.00 |
| Dec 31, 2020 | 35,292.00 |
| Sep 30, 2020 | 39,500.00 |
| Jun 30, 2020 | 38,366.00 |
| Mar 31, 2020 | 38,169.00 |
| Dec 31, 2019 | 45,086.00 |
| Sep 30, 2019 | 49,094.00 |
| Mar 31, 2019 | 58,825.00 |
| Dec 31, 2018 | 62,935.00 |